Arterra Bioscience Operating Cash Flow for the year ending December 31, 2023:
USD 1.13 M
Arterra Bioscience Operating Cash Flow is USD 1.13 M for the year ending December 31, 2023, a -24.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Arterra Bioscience Operating Cash Flow for the year ending December 31, 2022 was USD 1.49 M, a -6.11% change year over year.
-
Arterra Bioscience Operating Cash Flow for the year ending December 31, 2021 was USD 1.59 M, a 171.27% change year over year.
-
Arterra Bioscience Operating Cash Flow for the year ending December 31, 2020 was USD 586.21 K, a -69.89% change year over year.
-
Arterra Bioscience Operating Cash Flow for the year ending December 31, 2019 was USD 1.95 M, a 78.64% change year over year.